Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation in Participants With Dementia of the Alzheimer's Type”

7 trials

Showing 7 of 7 results

Testing effectiveness (Phase 2)Looking for participantsNCT05543681
What this trial is testing

Clinical Trial on Agitation in Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseAgitation,PsychomotorCare Giving Burden+2 more
IGC Pharma, LLC 164
Large-scale testing (Phase 3)Study completedNCT02442778
What this trial is testing

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Participants With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 522
Testing effectiveness (Phase 2)Looking for participantsNCT06808984
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer Disease
Celgene 120
Large-scale testing (Phase 3)Looking for participantsNCT05397639
What this trial is testing

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

Who this might be right for
AgitationAlzheimer's Type Dementia
Suven Life Sciences Limited 375
Early research (Phase 1)Study completedNCT05227118
What this trial is testing

MK-8189 Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)Study completedNCT01584440
What this trial is testing

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer's Disease
Avanir Pharmaceuticals 220
Large-scale testing (Phase 3)Not Yet RecruitingNCT07284472
What this trial is testing

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Who this might be right for
Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH 300

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation